Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Alpha Technology Group	ATGL	5. nov 2024	8.51	-3.19
Alpha Teknova	TKNO	5. nov 2024	6.71	-3.03
Alphabet A	GOOGL	5. nov 2024	169.74	+0.30
Alphabet C	GOOG	5. nov 2024	171.41	+0.43
AlphaMark Actively Managed Small Cap ETF	SMCP	5. nov 2024	33.24	+2.07
Alphatec	ATEC	5. nov 2024	8.58	+2.63
AlphaTime Acquisition	ATMC	5. nov 2024	11.28	0.00
AlphaVest Acquisition	ATMV	5. nov 2024	11.23	+0.09
AlphaVest Acquisition Unit	ATMVU	5. nov 2024	11.31	0.00
Alpine Income Property	PINE	5. nov 2024	18.00	+1.29
Alps Alerian MLP ETF	AMLP	5. nov 2024	47.49	+1.50
Alps Equal Sector Weight ETF	EQL	5. nov 2024	127.00	+0.92
Alps International Sector Divid	IDOG	5. nov 2024	30.78	+0.63
Alps Sector Dividend Dogs ETF	SDOG	5. nov 2024	58.75	+1.03
Alset EHome International	AEI	5. nov 2024	1.42	0.00
Alt5 Sigma	ALTS	5. nov 2024	2.28	-3.39
Alta Equipment A Pref	ALTG-A	5. nov 2024	25.50	-0.58
Alta Equipment Group A	ALTG	5. nov 2024	6.51	-2.40
Alta Global Group	MMA	5. nov 2024	2.48	+4.64
Altair Engineering A	ALTR	5. nov 2024	104.52	+0.51
Altamira Therapeutics	CYTO	5. nov 2024	0.52	+0.39
AltEnergy Acquisition A	AEAE	5. nov 2024	11.22	0.00
AltEnergy Acquisition Unit	AEAEU	5. nov 2024	11.30	0.00
Alterity Therapeutics ADR	ATHE	5. nov 2024	1.18	+3.89
Alternus Clean Energy A	ALCE	5. nov 2024	2.38	-0.42
Alti Global A	ALTI	5. nov 2024	4.67	+8.10
Altice USA A	ATUS	5. nov 2024	2.53	-2.32
Altimmune	ALT	5. nov 2024	7.03	+3.53
Altisource Portfolio Solutions	ASPS	5. nov 2024	1.14	-4.20
Alto Ingredients	ALTO	5. nov 2024	1.93	-0.52

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.